Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ly-Mee Yu

Showing results (141-150 of 185) with videos related to

Pageof 19
Sort By:
The Lancet. Healthy Longevity|August 2, 2024
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trialJames P Sheppard, Eleanor Temple, Ariel Wang, et al.
BMJ Open|October 6, 2018
OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trialJames P Sheppard, Jenni Burt, Mark Lown, et al.
JAMA|May 27, 2020
Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical TrialJames P Sheppard, Jenni Burt, Mark Lown, et al.
The Lancet. Psychiatry|April 8, 2022
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analysesDaniel Freeman, Sinéad Lambe, Thomas Kabir, et al.
Trials|June 9, 2019
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)Belinda Lennox, Ksenija Yeeles, Peter B Jones, et al.
Trials|July 20, 2016
A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocolCaroline Greenan, Lynn Murphy, Ly-Mee Yu, et al.
Trials|October 3, 2024
Utilising primary care electronic health records to deliver the ALABAMA randomised controlled trial of penicillin allergy assessmentShadia Ahmed, Joanne Fielding, Catherine E Porter, et al.
Psychological Medicine|April 3, 2023
The Oxford Agoraphobic Avoidance ScaleSinead Lambe, Jessica C Bird, Bao Sheng Loe, et al.
BMJ Open|January 1, 2020
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D Feasibility): a randomised feasibility trial protocolAndrew Farmer, Julie Allen, Kiera Bartlett, et al.
Health Technology Assessment (Winchester, England)|June 25, 2019
Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCTMelissa Kapoor, Will Storrar, Lara Balls, et al.
Pageof 19

Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
The Lancet. Healthy Longevity|August 2, 2024
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trialJames P Sheppard, Eleanor Temple, Ariel Wang, et al.
BMJ Open|October 6, 2018
OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trialJames P Sheppard, Jenni Burt, Mark Lown, et al.
JAMA|May 27, 2020
Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical TrialJames P Sheppard, Jenni Burt, Mark Lown, et al.
The Lancet. Psychiatry|April 8, 2022
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analysesDaniel Freeman, Sinéad Lambe, Thomas Kabir, et al.
Trials|June 9, 2019
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)Belinda Lennox, Ksenija Yeeles, Peter B Jones, et al.
Trials|July 20, 2016
A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocolCaroline Greenan, Lynn Murphy, Ly-Mee Yu, et al.
Trials|October 3, 2024
Utilising primary care electronic health records to deliver the ALABAMA randomised controlled trial of penicillin allergy assessmentShadia Ahmed, Joanne Fielding, Catherine E Porter, et al.
Psychological Medicine|April 3, 2023
The Oxford Agoraphobic Avoidance ScaleSinead Lambe, Jessica C Bird, Bao Sheng Loe, et al.
BMJ Open|January 1, 2020
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D Feasibility): a randomised feasibility trial protocolAndrew Farmer, Julie Allen, Kiera Bartlett, et al.
Health Technology Assessment (Winchester, England)|June 25, 2019
Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCTMelissa Kapoor, Will Storrar, Lara Balls, et al.
Pageof 19